Cargando…
Doxorubicin-Loaded Polymeric Micelles Conjugated with CKR- and EVQ-FLT3 Peptides for Cytotoxicity in Leukemic Stem Cells
Doxorubicin (Dox) is the standard chemotherapeutic agent for acute myeloblastic leukemia (AML) treatment. However, 40% of Dox-treated AML cases relapsed due to the presence of leukemic stem cells (LSCs). Thus, poloxamer 407 and CKR- and EVQ-FLT3 peptides were used to formulate Dox-micelles (DMs) and...
Autores principales: | Chueahongthong, Fah, Tima, Singkome, Chiampanichayakul, Sawitree, Dejkriengkraikul, Pornngarm, Okonogi, Siriporn, Sasarom, Mathurada, Rodwattanagul, Soraya, Berkland, Cory, Anuchapreeda, Songyot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610626/ https://www.ncbi.nlm.nih.gov/pubmed/36297550 http://dx.doi.org/10.3390/pharmaceutics14102115 |
Ejemplares similares
-
Co-Treatments of Edible Curcumin from Turmeric Rhizomes and Chemotherapeutic Drugs on Cytotoxicity and FLT3 Protein Expression in Leukemic Stem Cells
por: Chueahongthong, Fah, et al.
Publicado: (2021) -
Anticancer activity of Zingiber ottensii essential oil and its nanoformulations
por: Panyajai, Pawaret, et al.
Publicado: (2022) -
A Novel Drug Modulator Diarylheptanoid (trans-1,7-Diphenyl-5-hydroxy-1-heptene) from Curcuma comosa Rhizomes for P-glycoprotein Function and Apoptosis Induction in K652/ADR Leukemic Cells
por: Viriyaadhammaa, Natsima, et al.
Publicado: (2022) -
CD123-Targeted Nano-Curcumin Molecule Enhances Cytotoxic Efficacy in Leukemic Stem Cells
por: Nirachonkul, Wariya, et al.
Publicado: (2021) -
Biological activities of extracts and compounds from Thai Kae-Lae (Maclura cochinchinensis (Lour.) Corner)
por: Rueankham, Lapamas, et al.
Publicado: (2023)